Hvis der ikke opretholdes klinisk relevante reduktioner i serumkalciumniveauet, bør det overvejes at afbryde Parareg- behandlingen (se punkt 5. 1).
After titration to the maximum dose of Parareg, serum calcium should be periodically monitored; if clinically relevant reductions in serum calcium are not maintained, discontinuation of Parareg therapy should be considered (see section 5.1).